Suppr超能文献

结核分枝杆菌对抗菌药物的耐药性。

Resistance to antimicrobial agents in Mycobacterium tuberculosis.

作者信息

Pfyffer G E

机构信息

Swiss National Center for Mycobacteria, Department of Medical Microbiology, University of Zurich, Gloriastrasse 30, CH-8028 Zurich.

出版信息

Acta Cient Venez. 2001;52 Suppl 1:36-9.

Abstract

According to the World Health Organization (WHO) more people will currently die of tuberculosis (TB) than in any other year in history. Of equal concern are the emergence and nosocomial transmission of multidrug-resistant (MDR) strains of Mycobacterium tuberculosis. Only recently, with the advent of new molecular biological techniques, the mechanisms of drug resistance in TB bacilli are more and more understood. In M. tuberculosis, the primary mechanism of drug resistance seems to be exclusively confined to chromosomal DNA and not, as in other bacteria, to mobile genetic elements as well.

摘要

据世界卫生组织(WHO)称,目前死于结核病(TB)的人数比历史上任何一年都多。同样令人担忧的是结核分枝杆菌多重耐药(MDR)菌株的出现和医院内传播。直到最近,随着新分子生物学技术的出现,结核杆菌耐药机制才越来越为人所知。在结核分枝杆菌中,耐药的主要机制似乎仅局限于染色体DNA,而不像其他细菌那样,也涉及移动遗传元件。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验